Upsala, Sweden

Peter Ten Dijke


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Upsala, SE (1998 - 1999)
  • Uppsalla, SE (1999)
  • Uppsala, SE (2001)

Company Filing History:


Years Active: 1998-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Peter Ten Dijke

Introduction

Peter Ten Dijke is a notable inventor based in Upsala, Sweden. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids and their applications in cancer treatment. With a total of four patents to his name, Ten Dijke's work has had a profound impact on medical research and therapeutic methods.

Latest Patents

Among his latest patents is the invention titled "Isolated nucleic acid molecules encoding Smad7." This invention describes nucleic acids that encode the Smad7 protein, including its fragments and biologically functional variants. The patent also covers polypeptides and fragments encoded by these nucleic acids, along with related antibodies. Additionally, methods and products for utilizing these nucleic acids and polypeptides are provided. Another significant patent is "Tissue-derived tumor growth inhibitors, methods of preparation and uses." This invention offers a method for inhibiting cytotoxic poisoning of normal cells in a subject by administering Transforming Growth Factor Beta. This approach is particularly beneficial for pediatric patients undergoing anti-neoplastic therapies such as radiation or chemotherapy.

Career Highlights

Throughout his career, Peter Ten Dijke has worked with various organizations, including Creative Biomolecules, Inc. and the Ludwig Institute for Cancer Research Limited. His work has been instrumental in advancing the understanding of tumor growth and the development of innovative therapeutic strategies.

Collaborations

Ten Dijke has collaborated with esteemed colleagues in his field, including Carl-Henrik Heldin and Kenneth K Iwata. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Peter Ten Dijke's innovative work and patents have significantly influenced the field of molecular biology and cancer treatment. His contributions continue to pave the way for new therapeutic approaches and enhance our understanding of complex biological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…